{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T04:33:36Z","timestamp":1761712416058,"version":"build-2065373602"},"reference-count":35,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T00:00:00Z","timestamp":1424390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[2015,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Bexsero, a new vaccine against\n                    <jats:italic>Neisseria meningitidis<\/jats:italic>\n                    serogroup B (MenB), is composed of 3 main recombinant proteins and an outer membrane vesicle component. One of the main bactericidal antigens, neisseria heparin binding antigen (NHBA), is present as a fusion protein with the accessory protein genome\u2010derived neisserial antigen (GNA) 1030 to further increase its immunogenicity. The gene encoding for GNA1030 is present and highly conserved in all\n                    <jats:italic>Neisseria<\/jats:italic>\n                    strains, and although orthologs are present in numerous species, its biologic function is unknown. Native mass spectrometry was used to demonstrate that GNA1030 forms a homodimer associated with 2 molecules of ubiquinone\u20108 (Ub8), a cofactor mainly involved in the electron transport chain and with antioxidant properties. Disc diffusion assays on the wild\u2010type and knockout mutant of GNA1030, in the presence of various compounds, suggested that GNA1030 is not involved in oxidative stress or electron chain transport\n                    <jats:italic>per se<\/jats:italic>\n                    , although it contributes to constitutive refilling of the inner membrane with Ub8. These studies shed light on an accessory protein present in Bexsero and reveal functional insights into the family of related proteins. On the basis of our findings, we propose to name the protein neisseria ubiquinone binding protein (NUbp).\u2014Donnarumma, D., Golfieri, G., Brier, S., Castagnini, M., Veggi, D., Bottomley, M. J., Delany, I., Norais, N.\n                    <jats:italic>Neisseria meningitis<\/jats:italic>\n                    GNA1030 is a ubiquinone\u20108 binding protein.\n                    <jats:italic>FASEB J.<\/jats:italic>\n                    29, 2260\u20102267 (2015).\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.fasebj.org\">www.fasebj.org<\/jats:ext-link>\n                  <\/jats:p>","DOI":"10.1096\/fj.14-263954","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T03:44:00Z","timestamp":1424922240000},"page":"2260-2267","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["<i>Neisseria meningitis<\/i>\n                    GNA1030 is a ubiquinone\u20108 binding protein"],"prefix":"10.1096","volume":"29","author":[{"given":"Danilo","family":"Donnarumma","sequence":"first","affiliation":[{"name":"Novartis Vaccines Siena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Golfieri","sequence":"additional","affiliation":[{"name":"Novartis Vaccines Siena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Brier","sequence":"additional","affiliation":[{"name":"Novartis Vaccines Siena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Castagnini","sequence":"additional","affiliation":[{"name":"Novartis Vaccines Siena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Veggi","sequence":"additional","affiliation":[{"name":"Novartis Vaccines Siena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew James","family":"Bottomley","sequence":"additional","affiliation":[{"name":"Novartis Vaccines Siena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Delany","sequence":"additional","affiliation":[{"name":"Novartis Vaccines Siena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Norais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,2,20]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"237","article-title":"Meningococcal disease: changes in epidemiology and prevention","volume":"4","author":"Chang Q.","year":"2012","journal-title":"Clin. Epidemiol."},{"key":"e_1_2_7_3_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2009.04.071","article-title":"Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis","author":"Holst J.","year":"2009","journal-title":"Vaccine"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00554-5"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603940103"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.287.5459.1816"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.539510"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.1265"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2004.08.006"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1099\/13500872-145-8-1817"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(02)00416-5"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2010.06.007"},{"key":"e_1_2_7_13_1","first-page":"67","article-title":"Production, characterization and control of MenB-vaccine \u201cFolkehelsa\u201d: an outer membrane vesicle vaccine against group B meningococcal disease","volume":"14","author":"Fredriksen J. H.","year":"1991","journal-title":"NIPH Ann"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M700295-MCP200"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.12.082"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002027"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1128\/JB.184.20.5625-5632.2002"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg602"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq249"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.1701"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M400001200"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2014.01.015"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2728(90)90106-E"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.066"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0915162107"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.289314"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/febs.12707"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00508-06"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2010.07612.x"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1110\/ps.041183305"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2010.03.015"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.resmic.2013.03.016"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.118513"},{"key":"e_1_2_7_34_1","first-page":"2","article-title":"Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro","author":"Bartolini E.","year":"2013","journal-title":"J. Extracell. Vesicles"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.036"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1437"}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.14-263954","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fj.14-263954","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.14-263954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:16:51Z","timestamp":1761693411000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fj.14-263954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,20]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.1096\/fj.14-263954"],"URL":"https:\/\/doi.org\/10.1096\/fj.14-263954","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"type":"print","value":"0892-6638"},{"type":"electronic","value":"1530-6860"}],"subject":[],"published":{"date-parts":[[2015,2,20]]},"assertion":[{"value":"2014-10-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-01-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-02-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}